Table 2 Demographic and clinical characteristics of the individuals included in the final analysis
Variable | Total (n, %) | Recurrence | |
|---|---|---|---|
No (n, %) | Yes (n, %) | ||
Total | 190 (100.0) | 146 (76.8) | 44 (23.2) |
Gender (%) | |||
Male | 107 (56.3) | 84 (57.5) | 23 (52.3) |
Age (in years; %) | |||
0–18 | 81 (42.6) | 62 (42.5) | 19 (43.2) |
19–60 | 98 (51.6) | 75 (51.4) | 23 (52.3) |
> 60 | 11 (5.8) | 9 (6.1) | 2 (4.5) |
Malaria recurrence | |||
1 episode | 34 (17.9) | – | 34 (77.3) |
2 episodes | 10 (5.3) | – | 10 (22.7) |
Time to first recurrence (in days) | |||
29–60 | 14 (7.4) | – | 14 (31.8) |
60–180 | 30 (15.8) | – | 30 (68.2) |
CYP2D6 activity score | |||
≤ 1a | 37 (19.5) | 25 (17.1) | 12 (27.3) |
≥ 1.5b | 153 (80.5) | 121(82.9) | 32 (72.7) |